Edwards Lifesciences Corporation Revenue 2008–2025
Edwards Lifesciences Corporation reported $6.07B of revenue for fiscal 2025. That was 11.5% higher than fiscal 2024. Compared with fiscal 2020, the change was +38.3%.
| Fiscal year | Revenue | Change (YoY) |
|---|---|---|
| FY 2025 | $6.07B | +11.5% |
| FY 2024 | $5.44B | -9.4% |
| FY 2023 | $6.00B | +11.6% |
| FY 2022 | $5.38B | +2.9% |
| FY 2021 | $5.23B | +19.3% |
| FY 2020 | $4.39B | +0.9% |
| FY 2019 | $4.35B | +16.8% |
| FY 2018 | $3.72B | +8.4% |
| FY 2017 | $3.44B | +15.9% |
| FY 2016 | $2.96B | +18.8% |
| FY 2015 | $2.49B | +7.4% |
| FY 2014 | $2.32B | +13.6% |
| FY 2013 | $2.05B | +7.7% |
| FY 2012 | $1.90B | +13.2% |
| FY 2011 | $1.68B | +16.0% |
| FY 2010 | $1.45B | +9.5% |
| FY 2009 | $1.32B | +6.8% |
| FY 2008 | $1.24B | — |
Source: Edwards Lifesciences Corporation SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open EW 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Edwards Lifesciences Corporation reported $6.07B of revenue for fiscal 2025. That was 11.5% higher than fiscal 2024. Compared with fiscal 2020, the change was +38.3%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Edwards Lifesciences Corporation
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeEdwards Lifesciences Corporation — frequently asked questions
What is Edwards Lifesciences Corporation's revenue?
Edwards Lifesciences Corporation (EW) reported revenue of $6.07B for fiscal year 2025, per its SEC filings.
How has Edwards Lifesciences Corporation's revenue changed over time?
Between fiscal 2008 and 2025, EW's revenue grew at roughly 9.8% per year (compound annual rate), from $1.24B to $6.07B.
Where does this data come from?
Figures are computed from Edwards Lifesciences Corporation's official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.